🇺🇸 FDA
Patent

US 8642604

Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents

granted A61PA61P11/00A61P11/06

Quick answer

US patent 8642604 (Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents) held by The Regents of the University of California expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61P, A61P11/00, A61P11/06, A61P19/02, A61P19/08